Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ETV5 antisense RNA 1 (non-protein coding) (ETV5-AS1)
- Target
- ETV5-AS1
- Molecular classification
- Long noncoding RNA (lncRNA), Antisense RNA, Non-protein-coding RNA
01
Overview
ETV5 antisense RNA 1 (ETV5-AS1) is a human long noncoding RNA gene transcribed antisense to the ETV5 gene on chromosome 3. Its sequence and genomic localization are annotated, but specific biological function remains undetermined for ETV5-AS1. By analogy to other antisense RNAs, it may modulate the transcription of ETV5 or other neighboring genes, influence chromatin structure, and affect gene regulation in a cis or trans-acting manner. There are currently no drugs or disease roles specifically attributed to ETV5-AS1; it appears as a molecular entity of interest within noncoding RNA research, particularly in epigenetics and transcriptional regulation[1][2][3][8][9][10][11].
- Other names
- ETV5 antisense RNA 1ETV5-AS1ETV5 antisense RNA 1 (non-protein coding)
02
Mechanism of action
Not applicable for drugs, but antisense RNAs generally regulate target gene expression by mechanisms such as promoter competition, transcriptional interference, RNA-RNA duplex formation, or modulation of chromatin structure
03
Biological functions
Regulation of gene expression via antisense mechanismsTranscriptional interference with sense strand ETV5 (potential, by analogy to other antisense RNAs, but direct function of ETV5-AS1 itself presently uncharacterized)May influence chromatin structure and local gene expression in cis and trans, as with other antisense RNAs
04
Disease associations
Other (no direct disease associations established for ETV5-AS1 itself, but antisense RNAs are implicated in cancer, imprinting disorders, and epigenetic regulation)
05
Safety considerations
None specified in the literature; as a noncoding RNA, safety concerns would relate generically to manipulation of noncoding RNAs in gene therapy contexts (e.g., off-target effects).
06
Interacting drugs
None. No drugs are currently documented that specifically target ETV5-AS1
07
Biomarkers
None established for ETV5-AS1. Some antisense RNAs are biomarkers in cancer and other diseases, but ETV5-AS1 does not appear on current lists
Beyond the preview
Go deeper on ETV5 antisense RNA 1 (non-protein coding) (ETV5-AS1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ETV5 antisense RNA 1 (non-protein coding) (ETV5-AS1).